Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential therapeutic applications beyond transplant ...
Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...
The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach ...
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results